The prescribing information explains dosing, safety warnings, and contraindications in the FDA label for Wegovy tablets
their association with SGLT-2 inhibitors requires further confirmation through large, randomized trials ( SGLT2 inhibitors should be discontinued in specific clinical scenarios to mitigate potential adverse events
They do this in several ways: They boost insulin release when blood sugar rises They reduce glucagon (a hormone that increases blood sugar) They slow down stomach emptying, which prevents blood sugar spikes after meals For people with type 2 diabetes, these effects can mean better control of blood sugar levels and lower A1C (a measure of average blood sugar over time)
Maximum efficacy is achieved at this level, and the body has had 12 weeks to adapt to the medications effects progressively
It requires planning, communication with your healthcare provider, careful monitoring (of body weight, appetite, blood sugar, side-effects), and realistic expectations for sustained weight management
How fast will I lose weight
